David Berkower, DO
Physical Medicine & Rehabilitation · Pembroke Pines, FLNPI 1043324429
Payments from drug & device makers
Across 281 payments — averaging $12.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$977
- Collegium Pharmaceutical, Inc.$853
- AbbVie$210
- Almatica Pharma LLC$187
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
- Pfizer$142
- plus $949 from 22 others
What the payments were for
- Food & beverage$3,466100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 70 | $977 |
| Collegium Pharmaceutical, Inc. | 102 | $853 |
| AbbVie(2 entities) | 16 | $210 |
| Almatica Pharma LLC | 18 | $187 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $149 |
| Pfizer | 8 | $142 |
| Medtronic(2 entities) | 3 | $105 |
| Amgen | 6 | $97 |
| Biodelivery Sciences International, Inc. | 6 | $82 |
| Redhill Biopharma Inc. | 5 | $79 |
| Azurity Pharmaceuticals, Inc. | 4 | $76 |
| Valinor Pharma, LLC | 3 | $61 |
| Daiichi Sankyo Inc. | 3 | $51 |
| Virtus Pharmaceuticals LLC | 4 | $50 |
| IBSA Pharma Inc. | 3 | $48 |
| Lilly USA, LLC | 3 | $41 |
| Tonix Medicines, Inc. | 2 | $40 |
| Boston Scientific | 1 | $33 |
| Zyla Life Sciences, Inc. | 2 | $32 |
| Protega Pharmaceutials Inc | 2 | $30 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Forte Bio-pharma LLC | 2 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Vertex | 1 | $16 |
| Electronic Waveform Lab, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
| Tersera Therapeutics LLC | 1 | $13 |
| Pacira Therapeutics, Inc. | 1 | $13 |
How this compares
$3,466 in reported general payments places this provider in the 85th percentile of 618 physical medicine & rehabilitation providers in Florida.
See all physical medicine & rehabilitation providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 45 | $41,160 |
| Xtampza ErOxycodone Myristate | 63 | $31,462 |
| MovantikNaloxegol Oxalate | 55 | $25,351 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 806 | $22,963 |
| Lidocaine | 240 | $22,247 |
| OxycontinOxycodone Hcl | 39 | $21,572 |
| Fentanyl | 69 | $8,309 |
| LyricaPregabalin | 12 | $8,276 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 357 | $5,571 |
| Gabapentin | 425 | $5,259 |
| Oxycodone Hcl | 280 | $5,259 |
| Pregabalin | 422 | $4,641 |
| Morphine Sulfate ErMorphine Sulfate | 144 | $3,025 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $2,674 |
| Diclofenac Sodium | 67 | $2,195 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $853 | $72,622108 claims |
| Redhill Biopharma Inc.Movantik | $79 | $25,35155 claims |
| PfizerLyrica | $142 | $8,27612 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $20 | $50132 claims |
| Virtus Pharmaceuticals LLCLactulose | $50 | $25321 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 618 physical medicine & rehabilitation providers in Florida.
Other physical medicine & rehabilitation in Pembroke Pines
- Alan MillerFernandina Beach$784K
- Anthony GiuffridaFort Lauderdale$443K
- Paul WuOakland Park$311K
- Marissa McCarthyTampa$239K
- Ryan HafnerSarasota$200K
- Cassandra ListJacksonville$154K
- Benjamin WesterhausMangonia Park$100K
- Michael YuClearwater$47K
- Jose Medina SanchezTampa$30K
- Anish SoniNaples$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.